To assess the role of changes in lung collagen in pulmonary fibrosis, the content of this protein was measured in biopsy and autopsy lung from patients with cryptogenic fibrosing alveolitis (CFA), a fibrotic lung disorder of unknown cause. The collagen concentration was measured in lung samples from 21 patients with CFA (14 autopsy and seven open-lung biopsy) and 17 normal subjects; total lung collagen was determined in the right lung of 10 patients who died from CFA and the results were compared with those from 10 normal lungs. There was a wide variation in the collagen concentrations but the mean value (+/- SEM) for patients with CFA (217 +/- 13 mg/g dry weight) was significantly higher (P less than 0.02) than that of the controls (155 +/- 15 mg/g dry weight). The mean collagen concentration of the autopsy samples (243 +/- 20 mg/g dry weight) was significantly higher (P less than 0.05) than that of the biopsy samples (165 +/- 24 mg/g dry weight). The mean total collagen was markedly raised (P less than 0.001) in right lungs of patients with CFA (32.5 +/- 4.3 g) compared with normal lungs (14.0 +/- 1.1 g). When corrected for the predicted lung volume this difference in total lung collagen remained statistically significant (P less than 0.01, mean for patients 4.7 +/- 0.7 mg/ml, controls 2.3 +/- 0.2 mg/ml). These results demonstrate an increased deposition of lung collagen in this form of pulmonary fibrosis. They also suggest that there is a greater collagen concentration in lungs of patients with later disease, indicating a progressive deposition of collagen during the course of the disease.
A hydropic neonate, born at 28 weeks gestation, died 45 minutes after birth. Autopsy showed an abnormally long and tortuous arterial duct which was occluded by laminated thrombus. The right heart chambers and the left ventricle were dilated, but there was no other structural cardiac abnormality. Apart from the abnormal ductal morphology, there was no evident cause for the intrauterine thrombosis of the arterial duct, which appeared to be the sole cause of fatal heart failure.A NTENATAL ABNORMALITIES OF THE ARTERIAL DUCT are rare. The duct may be completely absent due to failure of development, or premature ductal closure may occur as a result of muscular constriction of the duct wall, usually a fatal event. We report a case of fetal hydrops followed by premature delivery and death due to thrombotic occlusion of an abnormally tortuous arterial duct. Case reportAn 18-year-old primigravida presented with premature labor at 28 weeks of pregnancy. Ultrasound scan of the fetus had been normal at 18 weeks gestation. Despite treatment with ritodrine and intramuscular dexamethasone, labor progressed to result in breech delivery of a male infant weighing 1380 gm with apgar scores of two at both one and five minutes. The baby died 45 minutes after delivery despite intensive resuscitative measures.Autopsy showed usual arrangement of the organs and atriums ("solitus") with normal systemic and pulmonary venous connections, an enlarged heart, very dilated right atrium, a large patent oval foramen, marked dilatation of the right ventricle, moderate dilatation of the left atrium and a slightly dilated left ventricle. The relationship and the morphology of the great arteries and their branches were normal but the aortic arch was slightly displaced medially by an unusually long and tortuous duct which lay alongside it. The duct was completely occluded by laminated thrombus but there was no evidence of ductal constriction. DiscussionThe fetal arterial duct is usually a short, wide vessel which plays a vital role in bypassing the high resistance circulation of the non-functioning lungs. The fetal right ventricle normally contributes about two-thirds of the total cardiac output, most of this crossing the arterial duct to provide about 85% of descending aortic flow, only about 10% of the output of the right ventricle being directed to the lungs.' Inability to shunt right-toleft across the duct during fetal life might, therefore, be expected to cause major hemodynamic upset with pressure overload of the right ventricle and volume overload of the left ventricle due to an inevitable substantial increase in right-to-left shunting across the oval foramen. 2,3Absence of development of the arterial duct may occur as a very rare anomaly without apparent untoward effects on fetal circulation if it is associated with other cardiac anomalies such as tetralogy of Fallot or common arterial trunk 1 which allow right to left shunting to take place at ventricular level rather than across the arterial duct. Absence of development of the duct
Background: Jehovah's Witness are convinced that biblical passages prohibit the transfusion of allogeneic blood and the predeposit of autologous whole blood for subsequent reinfusion. Medical literature reports several cases of complex medical and surgical procedures performed successfully without the use of allogeneic blood transfusions or its main components. In order to avoid blood transfusions, it is essential to use clinical strategies to minimize blood loss, to save autologous whole blood (AWB), to enhance hematopoiesis and to optimize the tolerance of anemia Methods: Herein we present a case of 71 years old manwith acute aortic dissection in a Jehovah's Witness patient (JW). Is a rare condition. Respecting the patient's will, a surgical procedure in high-risk surgical emergencywas performed without the use of blood transfusions,but applying our “bloodless protocol”, which can be considered as an extreme patient blood management protocol (PBM), in which the aim is to avoid the need for transfusions. Conclusion: Scientific literature and our twenty-year-experience with JW patients allowed us to show how an adequate strategy, a concrete project and a multidisciplinary bloodlessteam can guarantee excellent results either in JW patients or alternatively in specific cases ofalteration of the coagulationsystem, even in emergency situations. A well-defined strategic plan can help reduce duration of hospitalization and hospital cost. This case report, suggests that high quality PBM could be reasonably extended to all patients admitted to hospital, with the vision that “we treat all patients like JWs”.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.